High-Dose Immunosuppressive Therapy (HDIT) for SSc: Results of 3 year follow-up demonstrate continued improvement in function and skin with stability in the lungs
Publication
, Conference
Furst, DE; McSweeney, PA; Crofford, LJ; McDonagh, KT; Sullivan, KM; Mayes, MD; Nelson, JL; Gooley, TA; Holmberg, LA; Chen, CS; Wener, MH ...
Published in: ARTHRITIS AND RHEUMATISM
September 1, 2004
Duke Scholars
Published In
ARTHRITIS AND RHEUMATISM
ISSN
0004-3591
Publication Date
September 1, 2004
Volume
50
Issue
9
Start / End Page
S693 / S693
Location
San Antonio, TX
Publisher
WILEY-LISS
Conference Name
68th Annual Scientific Meeting of the American-College-of-Rheumatology/39th Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals
Related Subject Headings
- Arthritis & Rheumatology
- 1117 Public Health and Health Services
- 1107 Immunology
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Furst, D. E., McSweeney, P. A., Crofford, L. J., McDonagh, K. T., Sullivan, K. M., Mayes, M. D., … Nash, R. A. (2004). High-Dose Immunosuppressive Therapy (HDIT) for SSc: Results of 3 year follow-up demonstrate continued improvement in function and skin with stability in the lungs. In ARTHRITIS AND RHEUMATISM (Vol. 50, pp. S693–S693). San Antonio, TX: WILEY-LISS.
Furst, D. E., P. A. McSweeney, L. J. Crofford, K. T. McDonagh, K. M. Sullivan, M. D. Mayes, J. L. Nelson, et al. “High-Dose Immunosuppressive Therapy (HDIT) for SSc: Results of 3 year follow-up demonstrate continued improvement in function and skin with stability in the lungs.” In ARTHRITIS AND RHEUMATISM, 50:S693–S693. WILEY-LISS, 2004.
Furst DE, McSweeney PA, Crofford LJ, McDonagh KT, Sullivan KM, Mayes MD, et al. High-Dose Immunosuppressive Therapy (HDIT) for SSc: Results of 3 year follow-up demonstrate continued improvement in function and skin with stability in the lungs. In: ARTHRITIS AND RHEUMATISM. WILEY-LISS; 2004. p. S693–S693.
Furst, D. E., et al. “High-Dose Immunosuppressive Therapy (HDIT) for SSc: Results of 3 year follow-up demonstrate continued improvement in function and skin with stability in the lungs.” ARTHRITIS AND RHEUMATISM, vol. 50, no. 9, WILEY-LISS, 2004, pp. S693–S693.
Furst DE, McSweeney PA, Crofford LJ, McDonagh KT, Sullivan KM, Mayes MD, Nelson JL, Gooley TA, Holmberg LA, Chen CS, Wener MH, Lee J, Henstorf G, Abidi M, Nash RA. High-Dose Immunosuppressive Therapy (HDIT) for SSc: Results of 3 year follow-up demonstrate continued improvement in function and skin with stability in the lungs. ARTHRITIS AND RHEUMATISM. WILEY-LISS; 2004. p. S693–S693.
Published In
ARTHRITIS AND RHEUMATISM
ISSN
0004-3591
Publication Date
September 1, 2004
Volume
50
Issue
9
Start / End Page
S693 / S693
Location
San Antonio, TX
Publisher
WILEY-LISS
Conference Name
68th Annual Scientific Meeting of the American-College-of-Rheumatology/39th Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals
Related Subject Headings
- Arthritis & Rheumatology
- 1117 Public Health and Health Services
- 1107 Immunology
- 1103 Clinical Sciences